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Background: Non-communicable diseases (NCD) constitute major public health problems 
globally, with an impact on morbidity and mortality ranking high and second to HIV/AIDS. 
Existing studies conducted in South Africa have demonstrated that people living with NCD rely 
on traditional herbal medicine (THM) primarily or in combination with conventional drugs. 
The primary research focus has been on the clinical and experimental aspects of THM use for 
NCD, with limited data on the economic impact of health care delivery. Therefore, the purpose 
of this study will be to determine the cost and utilization of resources on THM in South Africa 
for NCD.
Materials and methods: Study describes the methods toward incorporating cost estimations 
and economic evaluation illustrated with the Prospective Urban and rural Epidemiological 
(PURE) study in South Africa. The South African PURE cohort is investigating the geographic 
and socioeconomic influence of THM spending and utilization, variations in spending based 
on perceived health status, marital status, and whether spending patterns have any impact on 
hospitalizations and disability. 
Data collection and evaluation plan: Since the individual costs of THM are not regulated 
nor do they have a standardized price value, information obtained through this study can be 
utilized to assess differences and determine underlying factors contributing to spending. This 
insight into THM spending patterns can aid in the development and implementation of guidelines 
or standardized legislation governing THM use and distribution. An economic evaluation and 
cost estimation model has been proposed, while the data collection is still ongoing. Particularly, 
willingness to pay method measures how much participants are willing to pay for THM for 
perceived improvements in health. Resource-use and expenditures along with annual direct 
costs for households will be determined.
Conclusion: Economic evaluations can provide insight for health care policy decision makers 
on the appropriate inclusion of THM to reduce the overall burden of health care costs in South 
Africa. Because of the increased prevalence of integrative medicine, it is crucial to consider 
potential implications and their use of comparative effectiveness research to incorporate comple-
mentary and alternative medicine in future.
Keywords: complementary medicine, alternative medicine, economics, comparative effective-
ness research, CAM
Background
Chronic non-communicable diseases (NCD), consisting of cardiovascular disease, type 
2 diabetes, chronic respiratory disease, and certain cancers currently account for 44% 
of premature deaths and 60% of all deaths worldwide.1 These diseases particularly 
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Table 1 list of commonly used medicinal plants in South Africa
Botanical name Common 
name
Uses
Aspalathus linearis  
(Burm.f.) R. dahlgren  
(Family: leguminosae)
Rooibos Stomach cramps, infant  
colic




treatment of cancer and  
hIV, improves appetite,  
boosts the immune system
harpagophytum procumbens  




hoodia gordonii (Masson)  
Sweet ex decne. (Family:  
Apocyanaceae)
hoodia Appetite suppressant
tulbaghia alliacea l.f.  
(Family: Amaryllidaceae)
Wild garlic Fevers and colds, asthma  
and tuberculosis






hypoxis hemerocallidea Fisch.  




Prostate problems, delaying 
hIV symptoms, tuberculosis, 
cancers, lung diseases
Abbreviation: HIV, human immunodeficiency syndrome.





Several factors have contributed to the increased burden of 
chronic NCD in these countries, which include lengthened 
average life span, decreases in physical activity, increases in 
consumption of unhealthy food, and continued tobacco use.1 
The combination of these factors has led to projections that 
the burden of these diseases will continue to rise by 15% 
globally between 2010 and 2020.2 Low- and middle-income 
countries, already facing a greater burden of chronic NCD, 
are expected to see a 20% increase over the same period.2 All 
of these factors together have led to chronic NCD becoming 
a top global health concern.
South Africa has been affected by particularly high rates 
of communicable diseases, such as the HIV/AIDS epidemic, 
but is now similarly facing a substantial burden of chronic 
NCD. In 2004, estimates by the World Health Organiza-
tion (WHO) suggested that chronic NCD, as measured by 
disability-adjusted life years, accounted for 28% of the total 
burden of disease in South Africa.3 These estimates place the 
burden of NCD in South Africa at two to three times that of 
most developed countries and similar to other sub-Saharan 
and central European countries.3 The rise in prevalence 
of chronic NCD largely can be attributed to demographic 
transitions and lifestyle changes as a result of urbaniza-
tion. High levels of modifiable risk factors that contribute 
to chronic NCD including tobacco use, physical inactivity, 
and unhealthy diets have all been reported in the South 
African adult population.4–6 Improved medical care has led 
to a lengthened life span for the South African population, 
with projections that the proportion of the population above 
60 years old is expected to grow at more than four times the 
rate of the general population.7 Socioeconomic disparities 
have resulted in the urban poor facing the largest burden of 
chronic NDC. In combination, these factors have resulted in 
a continually evolving and complex burden of disease and an 
increased prevalence of chronic NCD in South Africa.
To treat these rapidly emerging chronic NCD, South Afri-
cans rely on Western pharmaceutical medicine, but also display 
widespread dependence on traditional herbal medicines (THM). 
The WHO defined THM as, “health practices, approaches, 
knowledge, and beliefs incorporating plant, animal and mineral 
based medicines, spiritual therapies, manual techniques and 
exercises, applied singular or in combination, to treat, diagnose 
and prevent illnesses or maintain well-being.”8 WHO estimates 
are that 80% of rural populations in developing countries 
depend on THM for their health care needs.9 Several cultural 
and socioeconomic factors contribute to the widespread utiliza-
tion observed throughout these populations. The use of THM 
in South Africa is an inherent, culturally accepted practice with 
traditional healers more positively viewed than the public health 
care system.10 The overall inadequacy of the South African 
health care system, in combination with the high cost of Western 
pharmaceutical medicine, serves to drive patients toward THM 
use.11 The relative ease of access and effectiveness of THM 
compared to conventional drugs, in terms of side effects, also 
contributes to patients preferentially selecting THM. Cultural 
acceptance, accessibility, and affordability all contribute to this 
observed THM utilization within the South African population. 
Some of the most commonly used medicinal plants are outlined 
in Table 1. So far, researchers have focused on the clinical and 
experimental aspects of THM use; hence, there exists a lack 
of available literature addressing the cost and utilization of 
THM for NCD. Therefore, the purpose for this study will be 
to determine the cost and utilization of resources on THM for 
NCD in South Africa.
Methodology
Study design and research plan
Through this cross-sectional descriptive study, we will per-
form economic analyses on THM use as an extension of the 
Prospective Urban and Rural Epidemiological (PURE) study 
in South Africa. The PURE study is a global population-based 
cohort study in 17 low-, middle-, and high-income countries. 
The primary aim of the PURE study is to examine societal 
influences, the prevalence of risk factors, incidence of chronic 
NCD, and changes in risk factor rates in the population 
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Figure 1 Study Sites: langa, Western Cape Province, and Mount Frere, Eastern 
Cape Province, South Africa.




Economic evaluation of thM spending in South Africa
clinical-medical history, socioeconomic status, and lifestyle 
behaviors were collected, and has been described elsewhere.12 
The PURE study methodology paper mentions that data were 
collected by an adult questionnaire; using two measures of 
resting blood pressure; fasting blood sample for biochemi-
cal and genetic testing; the Framingham Risk Score and its 
components and the prevalence of cardiovascular disease.12 
These data and questions on THM use will be used to link 
NCD and THM.
Utilizing the pre-existing PURE study questionnaire, we 
will be obtaining additional information at the individual, 
household, and community level on the expenditure and uti-
lization of THM for chronic NCD. Using this information, an 
economic evaluation will be conducted to assess how family 
structure, socioeconomic status, and health care utilization 
influence, and are influenced by THM use. By using willing-
ness to pay methods, we will be able to measure cost benefit 
analysis, and answer how much they are willing to pay for 
THM for perceived improvements in health.
Study setting
The current investigation will be conducted on the PURE 
study sample in Langa, an urban township located in Cape 
Town in the Western Cape Province, and Mount Frere, 
a small rural town located in the Eastern Cape Province, 
South Africa (Figure 1).
Sampling for PURE – South Africa
The cohort was drawn to represent the adult population 
resident in both communities (Langa and Mount Frere) 
but also with mindfulness to the possibility of follow-up of 
participants. These communities were purposely selected 
on the basis of having a relatively stable (less migratory) 
black population, thus allowing for feasibility of follow-up 
in a prospective cohort study. For the urban community 
(Langa), households were grouped into three development 
areas recognized administratively by the City of Cape Town 
and which mirror the socioeconomic status of the residents. 
A street map obtained from the City of Cape Town was used 
to randomly select streets in each of the three areas. Once 
a street was selected, a systematic sample of every second 
house was approached for possible inclusion in the study.
Households’ eligibility was based on the criteria that at least 
one member should be between ages 30 and 70 years, and that 
this person intends to live in the current home for the following 4 
years. All households with eligible individuals were approached 
by trained field workers for recruitment. All individuals who 
were “usual residents” were considered “household members” 
and eligible to be selected for the study. A “usual resident” was 
defined as one “who eats and sleeps in the household on most 
days of the week and in most weeks of the year and considered 
the household his/her primary place of habitation”.
For the rural community (Mount Frere), the absence of 
delineated streets precluded the possibility to follow the same 
sampling approach used for the urban township. Therefore, 
a cluster sampling approach of houses in the community 
was undertaken according to the division of areas by the 
clan heads. All households within the clusters were included 
provided that there should be a household member aged 
30–70 years. The initial recruitment took place between April 
and August 2009 with close to 1,000 participants recruited 
in both locations. A second phase recruitment took place 
between April and August 2010. The response rate was 85%. 
All the individuals who agreed to participate provided written 
informed consent.
Sampling for the current study
The sampling frame for the current study includes the 
2,000 participants who took part in the original South 
African PURE study. An administrative spreadsheet used 
to capture participants’ information throughout the PURE 
follow-up period will be used to randomly select a sample 
of 1,000 participants comprising 500 participants from the 
rural site and 500 participants from the urban site. To facilitate 
the data collection process, their names, contact details, and 
residential addresses were noted.
data collection plan
We will align PURE THM study with the larger PURE study. 
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for follow-up and anthropometric measures. Appointments 
with participants to collect data will be made by means of 
a telephone call. Using their residential addresses, trained 
interviewers will visit the households/individuals on the day 
of the appointment to collect data on the epidemiology of 
THM use for chronic conditions. All the data will be col-
lected (2013–2014) using structured questionnaires admin-
istered by means of face-to-face interviews. The interviews 
conducted by trained data collectors will be in the preferred 
language of the respondent (English or Xhosa). Respondents’ 
demographic characteristics’ (age, sex, education, marital 
and employment status), clinical-medical history, and THM 
usage (duration of use, condition for use, dosage, and form) 
will be recorded. The PURE THM sub-study addressed ques-
tions as follows: basic demographics; medical-clinical char-
acteristics – general well-being; visits to clinic and hospital; 
level of illness/disability; any NCD/conditions; medication 
use both conventional/prescription; health seeking behavior; 
question on migration patterns (urban/rural); traditional 
medicine/complementary and alternative medicine (CAM) 
use – practice, type of medicines/practice and for what con-
dition; frequency and purpose; length of practice; opinions/
belief of practice (Likert scale); and economics of THM 
use – monthly expenditure. We will be collecting informa-
tion on: source of THM - whether provided by practitioner 
or self-administered; location of purchase/acquisition; type 
of THM - whether plant or herbal; and method of THM 
administration - whether ingested as tea or tincture, or in 
another form etc. The quality of data collected is maintained 
by using standardized protocols and centralized training. The 
additional economic questions utilized in our study have 
been developed and validated based on evidence provided 
through previously conducted research.13–20 These additional 
cost estimation questions are:
•	 How much do you spend (South African Rand, ZAR) on 
herbal remedies monthly/yearly?
•	 How much did you/your family pay (ZAR) for herbal 
remedies last year?
•	 What percentage of your income/family income have you 
spent on herbal remedies last year/last month?
•	 How much are you willing to pay (ZAR) for herbal rem-
edies to feel better?
•	 How much are you/your family members willing to pay 
(ZAR) for herbal remedies per year?
Studies conducted in the future could modify these 
questions to best reflect specific demographic and cultural 
aspects of the population being evaluated. The large size 
and extended duration of this study, in combination with 
the resultant familiarity of the South African population 
with the research team will all likely serve to strengthen the 
results obtained and increase the robustness and reliability 
of our findings.
The Senate Research Committee of the University of the 
Western Cape, South Africa, approved the study protocol.
Economic evaluation procedure
To assess the role and importance of economic evaluation of 
THM use for chronic NCD, cost-analysis, cost-comparison, 
cost-benefit, and multiple sensitivity analyses will be 
conducted. These economic evaluations will be performed to 
determine a variety of factors regarding patients’ THM use 
and overall health care expenditure from their viewpoint. All 
results will be reported in ZAR utilizing the 2013 value. This 
information can be analyzed to determine THM spending pat-
terns at the individual, household, and community levels. The 
study will assess the geographic and socioeconomic influence 
of THM spending and utilization, variations in spending 
based on perceived health status, marital status, and whether 
spending patterns have any impact on hospitalizations and 
disability. Several regression models will be developed to 
assess spending determinants. Patient willingness to pay 
methods and economic data will be utilized to perform cost-
benefit analyses regarding THM use. Costs will be calculated 
on a weekly, monthly, or annual basis to determine temporal 
relationships associated with THM spending and utilization. 
Data will be further extrapolated to determine direct health 
care costs, and the impact of THM utilization on health out-
comes and expenditure. The methodology of our study design 
is shown in Figure 2. As the figure displays, the PURE study 
serves to provide the background demographic information 
at the community and household levels. Using this informa-
tion, an economic evaluation will be conducted to assess 
how family structure, socioeconomic status, and health care 
utilization impact on, or are impacted by THM use.
We will be collecting household and community level 
estimates on the expenditure and utilization of THM for 
chronic NCD from this population. Individually, we will ask 
them, “How much do you spend (ZAR) on herbal remedies 
monthly?”, and “How much did you/your family pay (ZAR) 
for herbal remedies?” We will also ask them how much they 
spent in the previous year. Based on these individual- and 
family-level data we will be able to calculate community-
level and eventually population-level spending, as this is a 
population-based epidemiological cohort study. We will be 
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Figure 2 Study design and conceptual framework.
Abbreviations: PURE, Prospective Urban and Rural Epidemiological; thM, 
traditional herbal medicines.




Economic evaluation of thM spending in South Africa
Sensitivity analysis
One-way sensitivity analyses will be conducted to determine 
independent associations between geographic location, employ-
ment status, educational level, marital status, and perceived 
health status on the prevalence of THM expenditure. Several 
hypothetical scenarios will also be analyzed to gather maximum 
and minimum cost ranges using the baseline demographic and 
economic data obtained from the survey. These parameters will 
include the effect of change in currency value both geographi-
cally and temporally throughout the study period, as well as 
comparisons to other study outcomes estimating the THM 
prevalence in South Africa.
Economic and policy implications
The results obtained can provide an abundance of information 
to guide economic and governmental policy decision-making. 
These data will enable appropriate health policy decision-
making, by informing policymakers on the prevalence and 
the geographic and socioeconomic determinants of THM 
expenditure within the population. Geographic variation in 
spending and THM costs will be determined and used to 
assess factors that correlate with THM use. Only two other 
studies using atopic dermatitis patients and pediatric patients 
characterized the utilization patterns of traditional Chinese 
medicine in Taiwan.21,22 Programs and initiatives can then be 
targeted toward identified areas of interest to provide educa-
tion and interventions in those sections of the population 
with the greatest need. Since the individual costs of THM 
are not regulated or have a standardized value, information 
obtained through this study can be utilized to assess these 
differences and determine underlying factors contributing to 
these disparities. This insight into spending patterns as well 
as the individual and population level factors that contribute 
toward THM spending can aid in the development and imple-
mentation of guidelines or standardized legislation governing 
THM use and distribution.
Comparative effectiveness research 
issues
The results of this study can be used to perform further studies 
assessing the comparative effectiveness of THM use within the 
South African population. Comparative effectiveness research 
(CER) is defined as a measure of the extent to which an inter-
vention, when deployed in the field in routine circumstances, 
does what it is intended to do for a specific population.23 Thus, 
effectiveness has become more of a measure of the real impact 
which a therapeutic option will have when used by a given 
population that is actually using that treatment in practice. 
Due to the increased prevalence of integrative medicine in 
this population, it is crucial to consider potential implications 
and their use on CER, as patients’ CAM use can influence 
clinical trial efficacy outcomes.
On the other hand, “efficacy”, as it is often used, has come 
to be defined as the extent to which a specific intervention is 
beneficial under ideal conditions.23 The common use of this 
term then refers more specifically to benefit derived from 
clinical trials, which provide the basis for most of the efficacy 
claims of medications. Globally, in locations where THM use 
is already standard practice in the population, assessing the 
comparative effectiveness of these treatments and evaluating 
their effects could prove more beneficial than attempting to 
alter people’s way of life by imposing westernized medicinal 
practices.
Currently, most trials that are conducted attempt to deter-
mine efficacy of treatment options; however, reverse research 
and CER are emerging as a pragmatic approach to optimiz-
ing global treatment options, especially considering costs. 
The best treatment option for a given patient or population 
is not necessarily the most efficacious, but the most effective. 
Utilizing information obtained through the current study can 
aid the overall economic impact on health care delivery in 
South Africa. It is important that decision-makers develop 
guidelines to address a standardized approach of incorporat-
ing CAM into CER.
As opposed to traditional clinical trials, CER also relies on 
input not only from the researchers, but also from all involved 
parties, including patients, physicians, and payers in the iden-
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included in the evaluation of the results and the dissemination 
of the findings.24 This allows the research to be meaningful to 
the patient population studied and the results to be shared with 
them, particularly utilization and costs. The South African 
population’s unique mixture of reliance on pharmaceutical 
medicine and THM ensures that this patient population can 
prove to be an ideal arena to conduct CER. Once available, we 
plan to share the results of this research with the population 
who participated in the data collection.
Education of health care professionals 
and special considerations
With current data largely unknown on the spending, utiliza-
tion, and reliance on THM for chronic NCD in the South 
African population, the results of this study will provide new 
pharmacoeconomic information. These data can be utilized to 
further investigate their comparative effectiveness. Economic 
data can provide an additional facet of analysis when con-
ducting CER by enabling the evaluation of the distribution 
and allocation of resources in patient populations of various 
levels of economic prosperity. The prevalence and economic 
implications of THM use on chronic NCD can highlight the 
importance to the health care community of inquiring about 
spending patterns and determining populations more likely to 
be reliant on THM. The unknown prevalence of THM expen-
diture and lack of personal, family, and societal level data 
could lead to detrimental and deleterious health effects for 
this population and the global population. This information 
can then be used to guide patient therapy, which impacts 
clinical decision-making at the patient and community level, 
eventually resulting in an improved quality of care at a lower 
cost. Through utilization of prevalence data in combination 
with economic analyses, the provision of the most effective 
therapeutic options for patients from varying degrees of 
socioeconomic prosperity can be implemented.
A similar study could be conducted in the United States, 
where an estimated 20% of the population relies on THM, 
commonly referred to as CAM, which accounts for annual 
expenditures in excess of US$27 billion.25,26 Integration of 
CAM within the health care system could be facilitated 
through CER to establish viable alternative treatment options 
for patients. Pharmacists could be uniquely qualified to aid in 
this integration; however, curricula are currently insufficient 
and would need to be altered to improve knowledge of these 
treatments. Perhaps third-party payers can utilize this guid-
ance to make informed, evidence-based decisions in their 
drug formulary processes. Expansion of the curriculum and 
an increased interest in CER can serve to aid in the education 
of providers and ultimately the integration of THM therapies. 
This information on utilization and cost, in conjunction with 
evidence on safety and efficacy of CAM could then be used 
by third-party payer organizations to possibly reduce health 
care costs while improving the overall quality of health care 
delivery.27
Limitations and strengths
Data collection is currently in progress, thus no outcome data 
are available at this point in time. Reproduction of a similar 
economic analysis might be difficult because of an inability 
to locate a large epidemiological study similar to the PURE 
study with which to partner. The current study primarily 
focuses on expenditures on THM; however, no efficacy data 
have been obtained. Therefore, we will be able to analyze the 
costs and spending patterns of the South African population, 
but cost-efficacy analyses will not be conducted as there 
are no outcome data. Willingness-to-pay methods are being 
utilized in this study to evaluate how much additional money 
a person with NCD is willing to pay to feel better, and will 
give us insight about a patient’s perception of THM use. Cost 
of each herbal medicine is not provided in this study, as the 
individual costs of THM are not regulated nor do they have 
a standardized price value in South Africa. Future studies 
conducted in this area could seek to pair cost information 
with patient outcomes and efficacy to perform cost-efficacy 
analyses and CER on THM. Similar research could also 
focus on adverse event monitoring, drug–herb interactions, 
and other clinical events associated with herbal medicine 
safety. A similar study could be conducted to determine the 
economic implications of herbal medication use in the United 
States, where an estimated 20% of the population is actively 
using herbal medications.25
Conclusion
Understanding the economic implications associated with the 
prevalent use of THM in South Africa can provide a foun-
dation for health policy decision-making. These results can 
be used to highlight issues associated with chronic NCD as 
well as the use of THM in the South African population. The 
awareness that is generated can be used as leverage to garner 
long-term commitment and involvement from interested par-
ties to provide aid and promote disease prevention.
Information obtained can help to direct future studies in 
this area, improve future public health initiatives within South 
Africa, and serve to optimize the integration of THM use with 
traditional pharmaceutical medicine to ultimately improve 
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